South America
-
Call for change to neonatal sepsis guidelines
Global guidelines for treatment of neonatal sepsis should be changed to advise different antibiotics in poor countries, according to the findings of a major study published today. Read more
-
Booster vaccine targets rogue variant
The first vaccine specifically tailored to tackle a new variant of COVID-19 is now being tested on volunteers, it was announced last night. Read more
-
Global operation shuts down medical fraudsters
More than 3,000 illegal medical web pages in the UK have been shut down or blocked yesterday as part of a global operation against criminals exploiting the pandemic for profit, it has been announced. Read more
-
Hospitalised shift workers more likely to test COVID-19 positive
Shift workers are more likely to test positive for COVID-19 in hospital compared to those who work in the daytime, according to new research. Read more
-
COVID-19 vaccines may protect against variants
Existing COVID-19 vaccines are likely to protect against the Brazilian coronavirus variant, scientists at the University of Oxford, UK, have reported. Read more
-
New malaria genome data published
New genome variation data on more than 7,000 malaria parasites will help in the development of treatments, surveillance tools for malaria control and elimination, British researchers have reported. Read more
-
Gout drug aids COVID-19 patients
A cheap drug used to treat gout helps to reduce the need for oxygen therapy among the most ill COVID-19 patients, according to the results of a small clinical trial. Read more
-
Hypertension link to social isolation during lockdown
Social isolation due to COVID-19 lockdowns is associated with an increase in blood pressure, according to a new Argentine study. Read more
-
Global action call on diabetes epidemic
The world is facing an epidemic of diabetes – and could save millions of lives by effective, low-cost interventions, experts say today. Read more
-
SARS-COV-2 strains classified – and G is dominant
There are now at least six strains of the COVID-19 virus – but it remains vulnerable to vaccines, according to a major new analysis. Read more